Ad therapy is promising for enhancing myocardial healing and preventing adverse remodeling following MI.[9] Like Ad, mRNA is another emerging gene therapy tool in the treatment of MI.[10] By utilizing mRNA molecules, such as VEGF,[5] researchers can provide specific instructions to heart cells and stimulate them to produce therapeutic proteins or factors that aid in tissue repair and regeneration. The gene discussed is VEGFA; the disease is myocardial infarction.